NCT02642679View on ClinicalTrials.gov

Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects

NACompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions

Split-thickness Skin Graft Donor Sites

Interventions

DEVICE

Opticell Ag

Opticell Ag+ applied to STSG donor site

Sponsors

Collaborators (1)

Medline Industries

All Listed Sponsors

collaborator

Medline Industries

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT02642679 - Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects | Biotech Hunter | Biotech Hunter